【券商聚焦】海通国际:香港医疗板块情绪回暖 看好创新药龙头信达生物

金吾财讯
Feb 24

(原标题:【券商聚焦】海通国际:香港医疗板块情绪回暖 看好创新药龙头信达生物(01801))金吾财讯|海通国际发布研报指,香港医疗保健板块本周表现强劲,恒生医疗保健指数上涨3.2%,跑赢恒生指数3.2个百分点。年初以来该指数累计涨幅达10.5%,显著优于大盘表现。板块回暖主要受信达生物与礼来达成88.5亿美元战略合作催化,该交易创下中国创新药企BD新纪录。 报告显示,子板块中医疗器械(+4.9%)...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10